Congenica is a leader in genomic medicine, providing a sophisticated software platform for the analysis, interpretation, and reporting of complex genomic data. Their solutions empower healthcare professionals and researchers to quickly and accurately diagnose rare diseases, personalize cancer treatments, and advance genomic research, ultimately improving patient outcomes. Congenica's platform is designed to handle large-scale genomic datasets, offering clinical decision support and streamlining the path from data to actionable insights.
Serves as the central hub for research and development, corporate strategy, global operations, and product innovation in genomic analysis software.
Located within the Wellcome Genome Campus, providing access to a vibrant ecosystem of leading genomics research institutions, cutting-edge facilities, and collaborative opportunities.
Fosters a collaborative, innovative, and science-driven environment, encouraging employees to contribute to meaningful advancements in genomic medicine. Emphasis on teamwork and a passion for improving patient lives.
Its location at the Wellcome Genome Campus underscores Congenica's deep roots in genomic science and its commitment to being at the forefront of bioinformatics innovation, facilitating direct interaction with the genomics community.
Congenica supports a global customer base through its headquarters in the UK and regional offices in the USA and China. This international footprint enables the company to provide localized sales, support, and collaboration for its genomic analysis platform, facilitating its adoption by hospitals, research institutions, and diagnostic laboratories worldwide. They actively participate in international research collaborations and serve users across Europe, North America, Asia-Pacific, and other regions.
Biodata Innovation Centre, Wellcome Genome Campus
Hinxton, Cambridge
Cambridgeshire
United Kingdom
Address: 125 High Street, FL 20, Office 2031, Boston, MA 02110
To expand Congenica's presence and adoption of its genomic analysis platform in the Americas, tailoring solutions to meet regional clinical and research needs.
Address: Building 2, No.1 Disheng Middle Street, Beijing E-Town, Daxing District, Beijing
To address the specific needs of the Chinese genomic medicine landscape, supporting rare disease diagnosis and precision oncology initiatives in the region.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Congenica' leadership includes:
Congenica has been backed by several prominent investors over the years, including:
Over the past 12 months, Congenica has significantly strengthened its executive team with key appointments in marketing, people operations, and product/technology, reflecting a strategic focus on growth and innovation. No major executive departures were publicly announced during this period.
Discover the tools Congenica uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
While Congenica's exact email format isn't publicly specified, companies in the tech and biotech sectors commonly use patterns like [first].[last]@[domain] or [first_initial][last]@[domain]. For Congenica, this would translate to formats based on congenica.com.
Likely formats include [first_initial][last]@congenica.com or [first].[last]@congenica.com
Format
jdoe@congenica.com or jane.doe@congenica.com
Example
75%
Success rate
Congenica News / Business Weekly • March 12, 2024
Congenica announced the appointment of Helen Messenger as its new Chief Marketing Officer. Messenger brings extensive experience in healthcare and technology marketing to lead Congenica's global marketing strategy and support its expansion....more
Congenica News / GenomeWeb • November 21, 2023
Congenica has introduced a new module for its platform designed to automate the interpretation of somatic cancer genomic data. This enhancement aims to streamline workflows for oncologists and researchers, providing faster insights for personalized cancer treatment....more
Congenica News / Precision Medicine Online • October 10, 2023
Research utilizing Congenica's genomic analysis platform has identified novel genetic variants associated with Systemic Lupus Erythematosus (SLE) in patients of African ancestry. This discovery contributes to a better understanding of the disease's genetic basis in diverse populations....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Congenica, are just a search away.